Health

Peanut Allergy Drug Slated for 2018

An Aug. 10, 2005 file photo shows the peanut butter production line at Sunland Inc's peanut plant in Portales, N.M. (AP Photo/Albuquerque Journal, Richard Pipes)
An Aug. 10, 2005 file photo shows the peanut butter production line at Sunland Inc’s peanut plant in Portales, N.M. (AP Photo/Albuquerque Journal, Richard Pipes)

 

(CNN) – Peanut allergies are a serious and growing health problem in the Western world, affecting millions of kids and their families.

But a fix could be on the way.

A small French biopharmaceutical company has developed a new product — similar to a nicotine patch — to help allergy sufferers significantly increase their peanut tolerance.

If all goes according to plan, DBV Technologies (DBVT) will begin selling its product to Americans in the first six months of 2018.

READ MORE

Tags
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker